Dittobio
Ditto Bio develops evolutionary therapies by leveraging insights from parasite biology to treat autoimmune diseases. The company utilizes an AI platform to screen parasite proteins that modulate the immune system for therapeutic potential. This approach aims to discover novel drug candidates for conditions like rheumatoid arthritis and multiple sclerosis.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Raised to date
$500KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Ditto Bio develops evolutionary therapies by leveraging insights from parasite biology to treat autoimmune diseases. The company utilizes an AI platform to screen parasite proteins that modulate the immune system for therapeutic potential. This approach aims to discover novel drug candidates for conditions like rheumatoid arthritis and multiple sclerosis.